These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7702643)

  • 41. Regulation of subthalamic neuron activity by endocannabinoids.
    Morera-Herreras T; Ruiz-Ortega JA; Taupignon A; Baufreton J; Manuel I; Rodriguez-Puertas R; Ugedo L
    Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When and where are N-acylethanolamine phospholipids and anandamide formed?
    Hansen HS; Moesgaard B; Hansen HH; Petersen G
    World Rev Nutr Diet; 2001; 88():223-7. PubMed ID: 11935960
    [No Abstract]   [Full Text] [Related]  

  • 43. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    Jacobsson SO; Fowler CJ
    Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.
    Lam PM; McDonald J; Lambert DG
    Br J Anaesth; 2005 May; 94(5):649-56. PubMed ID: 15722382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anandamide and other N-acylethanolamines in human tumors.
    Schmid PC; Wold LE; Krebsbach RJ; Berdyshev EV; Schmid HH
    Lipids; 2002 Sep; 37(9):907-12. PubMed ID: 12458627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
    Smith PB; Compton DR; Welch SP; Razdan RK; Mechoulam R; Martin BR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):219-27. PubMed ID: 8035318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages.
    Di Marzo V; De Petrocellis L; Bisogno T; Maurelli S
    Adv Exp Med Biol; 1997; 407():341-6. PubMed ID: 9321974
    [No Abstract]   [Full Text] [Related]  

  • 49. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.
    Rakhshan F; Day TA; Blakely RD; Barker EL
    J Pharmacol Exp Ther; 2000 Mar; 292(3):960-7. PubMed ID: 10688610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
    Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
    J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.
    Bisogno T; Sepe N; De Petrocellis L; Mechoulam R; Di Marzo V
    Biochem Biophys Res Commun; 1997 Oct; 239(2):473-9. PubMed ID: 9344854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
    Sugiura T; Kobayashi Y; Oka S; Waku K
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.
    Weidenfeld J; Feldman S; Mechoulam R
    Neuroendocrinology; 1994 Feb; 59(2):110-2. PubMed ID: 8127398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of fatty acid amides in the carrageenan-induced paw edema model.
    Wise LE; Cannavacciulo R; Cravatt BF; Martin BF; Lichtman AH
    Neuropharmacology; 2008 Jan; 54(1):181-8. PubMed ID: 17675189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
    Paria BC; Das SK; Dey SK
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phospholipase participation in cannabinoid-induced release of free arachidonic acid.
    Burstein S; Budrow J; Debatis M; Hunter SA; Subramanian A
    Biochem Pharmacol; 1994 Sep; 48(6):1253-64. PubMed ID: 7945419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes.
    Sasaki T; Chang MC
    Life Sci; 1997; 61(18):1803-10. PubMed ID: 9365227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes.
    Bisogno T; Maurelli S; Melck D; De Petrocellis L; Di Marzo V
    J Biol Chem; 1997 Feb; 272(6):3315-23. PubMed ID: 9013571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.